'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Bilcare Limited
BI (NSE) · BI (BSE 526853) · ISIN INE986A01012 · Healthcare Research Analytics & Technology · Est. 1987 · listed 2026 · website
ESM Stage 1 · NSE ESM Stage 1 · BSE
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹1.94 cr and profit after tax ₹1.04 cr. Revenue was 6.3% lower than in Q1 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹1.94 cr | ₹1.04 cr | 0.44 | 13 Aug 2026 |
| Q4 FY26 standalone | ₹1.2 cr | −₹6.35 cr | −2.70 | 30 May 2026 |
| Q3 FY26 standalone | ₹1.73 cr | ₹2.71 cr | 1.15 | 12 Feb 2026 |
| Q2 FY26 standalone | ₹1.85 cr | ₹1.04 cr | 0.44 | 14 Nov 2025 |
| Q1 FY26 standalone | ₹2.07 cr | ₹3.59 cr | 1.52 | 14 Aug 2025 |
| Q4 FY25 standalone | ₹4.13 cr | ₹3.36 cr | 1.43 | 29 May 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹420.89 cr | ₹11.87 cr | ₹455.12 cr |
| 30 Sep 2025 standalone | ₹424.3 cr | ₹11.98 cr | ₹458.06 cr |
| 31 Mar 2025 standalone | ₹419.68 cr | ₹10.82 cr | ₹452.21 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 30.01% | 0.04% | — | 69.99% |
Latest filings
- Annual Report FY2025-26 (New) 4 September 2026 · BSE
- Bilcare Limited has informed the Exchange about Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30 June 2026 along with Limited Review Report issued by Statutory .... 13 August 2026 · BSE
- Bilcare Limitedhas informed the Exchange about the outcome of Board Meeting. 13 August 2026 · BSE
- Bilcare Limited has informed the Exchnage that the Board of Directors in their Meeting held on 29 May 2026 have approved Audited Financial Results (Standalone and Consolidated) for the .... 30 May 2026 · BSE
- Bilcare Limited has informed the Exchange about the outcome of Board Meeting held on 29 May 2026 30 May 2026 · BSE
Other companies in Healthcare Research Analytics & Technology
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 September 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.